Actively Recruiting
Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
Led by Kenyatta National Hospital · Updated on 2026-01-12
1980
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
K
Kenyatta National Hospital
Lead Sponsor
E
Emory University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).
CONDITIONS
Official Title
Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women ages 25-49 years
You will not qualify if you...
- Pregnant women
- Women 6 weeks postpartum or less
- Women already confirmed to have cervical cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kenyatta National Hospital
Nairobi, Kenya
Actively Recruiting
Research Team
A
Agnes K Karume, MBChB, MBA, MPH
CONTACT
M
Millicent Masinde, MBChB, MMed, Fell.Gyn Oncology
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here